ABLE Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$627K Sell
2,492
-32
-1% -$6.88K 0.11% 125
2026
Q1
$549K Sell
2,524
-190
-7% -$42.1K 0.11% 128
2025
Q4
$620K Buy
2,714
+53
+2% +$12.1K 0.13% 117
2025
Q3
$616K Sell
2,661
-260
-9% -$52.9K 0.13% 111
2025
Q2
$542K Sell
2,921
-47
-2% -$8.73K 0.13% 116
2025
Q1
$622K Hold
2,968
0.17% 90
2024
Q4
$527K Hold
2,968
0.16% 99
2024
Q3
$586K Sell
2,968
-218
-7% -$40.7K 0.18% 88
2024
Q2
$546K Buy
3,186
+137
+4% +$22.7K 0.2% 84
2024
Q1
$555K Buy
3,049
+188
+7% +$32.4K 0.22% 81
2023
Q4
$443K Buy
2,861
+9
+0.3% +$1.31K 0.19% 93
2023
Q3
$425K Sell
2,852
-68
-2% -$9.98K 0.21% 84
2023
Q2
$393K Buy
2,920
+653
+29% +$95.8K 0.2% 84
2023
Q1
$361K Buy
+2,267
New +$347K 0.24% 87

Other funds holding ABBV

ABLE Financial Group's ABBV Position: Q2 2026 in Review

ABLE Financial Group reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $6.88K and leaving 2,492 shares worth $627K. The position accounts for 0.11% of the portfolio, ranked #125.

ABLE Financial Group first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ABLE Financial Group held 2,492 shares of AbbVie worth $627K as of Q2 2026.
  • ABLE Financial Group sold 32 AbbVie shares in Q2 2026, an estimated $6.88K.
  • AbbVie made up 0.11% of ABLE Financial Group's portfolio in Q2 2026, its #125 holding.
  • ABLE Financial Group first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ABLE Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.